| NCT07089121 | Descartes-08 for Children, Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus, ANCA-associated Vasculitis, Juvenile Myasthenia Gravis, and Juvenile Dermatomyositis | NOT_YET_RECRUITING | PHASE1, PHASE2 | 2025-12 | 2026-12 | 2026-12 |
| NCT06799247 | Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis | RECRUITING | PHASE3 | 2025-05-06 | 2027-09-30 | 2026-11-30 |
| NCT06304636 | Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma | ACTIVE_NOT_RECRUITING | PHASE1 | 2024-06-19 | 2027-10-01 | 2026-12-01 |
| NCT06038474 | Descartes-08 for Patients With Systemic Lupus Erythematosus | RECRUITING | PHASE2 | 2024-02-12 | 2026-11-01 | 2025-11-01 |
| NCT04816526 | Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy | TERMINATED | PHASE2 | 2021-12-01 | 2022-11-03 | 2022-08-04 |
| NCT05113342 | Descartes-25 in Relapsed/Refractory Multiple Myeloma | TERMINATED | PHASE1 | 2021-11-25 | 2024-11-08 | 2023-05-09 |
| NCT04436029 | Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy | COMPLETED | PHASE2 | 2021-02-24 | 2022-04-09 | 2022-02-18 |
| NCT04524962 | Study of Descartes-30 in Acute Respiratory Distress Syndrome | TERMINATED | PHASE1 | 2021-02-23 | 2023-09-09 | 2022-09-09 |
| NCT04146051 | Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) | ACTIVE_NOT_RECRUITING | PHASE2 | 2019-12-04 | 2026-03-31 | 2025-07-31 |
| NCT03994705 | Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma | TERMINATED | PHASE1 | 2019-08-01 | 2021-06-11 | 2021-05-27 |
| NCT03448978 | Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma | TERMINATED | PHASE1 | 2018-03-08 | 2021-06-03 | 2021-04-19 |